Neonatal Data Analysis Unit, Imperial College London, London, UK.
Neonatal Unit, Barts and the London School of Medicine and Dentistry, Homerton Hospital, London, UK.
Lancet Gastroenterol Hepatol. 2017 Jan;2(1):43-51. doi: 10.1016/S2468-1253(16)30117-0. Epub 2016 Nov 8.
Necrotising enterocolitis is a neonatal gastrointestinal inflammatory disease with high mortality and severe morbidity. This disorder is growing in global relevance as birth rates and survival of babies with low gestational age improve. Population data are scant and pathogenesis is incompletely understood, but enteral feed exposures are believed to affect risk. We aimed to quantify the national incidence of severe necrotising enterocolitis, describe variation across neonatal networks, and investigate enteral feeding-related antecedents of severe necrotising enterocolitis.
We undertook a 2-year national surveillance study (the UK Neonatal Collaborative Necrotising Enterocolitis [UKNC-NEC] Study) of babies born in England to quantify the burden of severe or fatal necrotising enterocolitis confirmed by laparotomy, leading to death, or both. Data on all liveborn babies admitted to neonatal units between Jan 1, 2012, and Dec 31, 2013, were obtained from the National Neonatal Research Database. In the subgroup of babies born before a gestational age of 32 weeks, we did a propensity score analysis of the effect of feeding in the first 14 postnatal days with own mother's milk, with or without human donor milk and avoidance of bovine-origin formula, or milk fortifier, on the risk of developing necrotising enterocolitis.
During the study period, 118 073 babies were admitted to 163 neonatal units across 23 networks, of whom 14 678 were born before a gestational age of 32 weeks. Overall, 531 (0·4%) babies developed severe necrotising enterocolitis, of whom 247 (46·5%) died (139 after laparotomy). 462 (3·2%) of 14 678 babies born before a gestational age of 32 weeks developed severe necrotising enterocolitis, of whom 222 (48·1%) died. Among babies born before a gestational age of 32 weeks, the adjusted network incidence of necrotising enterocolitis ranged from 2·51% (95% CI 1·13-3·60) to 3·85% (2·37-5·33), with no unusual variation from the adjusted national incidence of 3·13% (2·85-3·42), despite variation in feeding practices. The absolute risk difference for babies born before a gestational age of 32 weeks who received their own mother's milk within 7 days of birth was -0·88% (95% CI -1·15 to -0·61; relative risk 0·69, 95% CI 0·60 to 0·78; number needed to treat to prevent one case of necrotising enterocolitis 114, 95% CI 87 to 136). For babies who received no compared with any bovine-origin products within 14 days of birth, the absolute risk difference was -0·65% (-1·01 to -0·29; relative risk 0·61, 0·39 to 0·83; number needed to treat 154, 99 to 345). We were unable to assess the effect of human donor milk as use was low.
Early feeding of babies with their own mother's milk and avoidance of bovine-origin products might reduce the risk of necrotising enterocolitis, but the absolute reduction is small. Owing to the rarity of severe necrotising enterocolitis, international collaborations are needed for adequately powered preventive trials.
National Institute for Health Research.
坏死性小肠结肠炎是一种具有高死亡率和严重发病率的新生儿胃肠道炎症性疾病。随着低胎龄婴儿出生率和存活率的提高,这种疾病在全球的相关性越来越大。人群数据稀缺,发病机制尚不完全清楚,但肠内喂养暴露被认为会影响风险。我们旨在量化严重坏死性小肠结肠炎的全国发病率,描述新生儿网络之间的差异,并研究与严重坏死性小肠结肠炎相关的肠内喂养相关因素。
我们进行了一项为期 2 年的全国性监测研究(英国新生儿协作坏死性小肠结肠炎[UKNC-NEC]研究),对英格兰出生的婴儿进行了剖腹证实的严重或致命坏死性小肠结肠炎的发病率进行了量化,导致死亡或两者兼而有之。2012 年 1 月 1 日至 2013 年 12 月 31 日期间,所有活产婴儿的入院数据均从国家新生儿研究数据库中获得。在胎龄小于 32 周的婴儿亚组中,我们对出生后前 14 天内使用母亲的初乳、人乳捐赠者的初乳和避免使用牛源配方奶粉或奶强化剂喂养的婴儿进行了 14 天内的倾向性评分分析,以评估其对患坏死性小肠结肠炎的风险。
在研究期间,163 个新生儿网络中的 118073 名婴儿入院,其中 14678 名婴儿胎龄小于 32 周。总体而言,531 名(0.4%)婴儿发生严重坏死性小肠结肠炎,其中 247 名(46.5%)死亡(139 名经剖腹证实)。14678 名胎龄小于 32 周的婴儿中,462 名(3.2%)发生严重坏死性小肠结肠炎,其中 222 名(48.1%)死亡。在胎龄小于 32 周的婴儿中,坏死性小肠结肠炎的网络发病率调整后从 2.51%(95%CI 1.13-3.60)到 3.85%(2.37-5.33)不等,尽管喂养方式存在差异,但与调整后的全国发病率 3.13%(2.85-3.42)相比,并无异常差异。胎龄小于 32 周的婴儿在出生后 7 天内接受母亲初乳的绝对风险差异为-0.88%(95%CI-1.15-0.61;相对风险 0.69,95%CI 0.60-0.78;预防 1 例坏死性小肠结肠炎所需的人数为 114 人,95%CI 87-136)。与出生后 14 天内未接受任何牛源产品的婴儿相比,未接受牛源产品的婴儿的绝对风险差异为-0.65%(-1.01-0.29;相对风险 0.61,95%CI 0.39-0.83;需要治疗的人数为 154 人,99-345)。我们无法评估人乳捐赠者初乳的效果,因为其使用量较低。
早期喂养婴儿自己的母亲的初乳和避免使用牛源产品可能会降低坏死性小肠结肠炎的风险,但绝对减少幅度较小。由于严重坏死性小肠结肠炎的罕见性,需要国际合作进行足够有力的预防试验。
英国国家卫生研究院。